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related quality of life (HRQOL) in patients with tuberculosis (TB), but
a psychometrically sound disease-speciﬁc instrument is lacking.
Objectives: The present study aimed to develop and psychometrically
validate a multidimensional TB-speciﬁc HRQOL instrument relevant
to the value of patients with pulmonary TB in Iraq with an eye toward
cross-cultural application. Methods: The core general HRQOL ques-
tionnaire is composed of the Functional Assessment of Cancer
Therapy-General items. A modular approach was followed for the
development of the Functional Assessment of Chronic Illness
Therapy-Tuberculosis (FACIT-TB) questionnaire in which a set of
items assessing quality-of-life (QOL) issues not sufﬁciently covered
by the core Functional Assessment of Cancer Therapy-General items,
but considered to be relevant to the target population, was added.
Moreover, principal-component analysis was used to determine the
new subscale structure of the questionnaire. Results: In addition toee front matter Copyright & 2015, International S
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.1016/j.vhri.2015.03.006
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la Lumpur, Malaysia.the 27 items of the core questionnaire, a set of 20 items referring to
disease symptoms related to the site of infection, adverse effects, and
additional QOL dimensions such as fatigue, social stigma, and eco-
nomic burden of the illness was included. Factor analysis demon-
strated that the FACIT-TB construct comprised ﬁve domains.
Conclusions: A rigorous method was applied in the development of
the FACIT-TB measure to fully understand the impact of TB on
patients’ QOL. The instrument is psychometrically sound and portrays
multiple important dimensions of HRQOL. FACIT-TB is relatively brief,
is easy to administer and score, and is appropriate for use in clinical
trials and practice.
Keywords: disease-speciﬁc instrument, FACT-G, health-related quality
of life, pulmonary tuberculosis, social stigma.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
For decades, health-related quality of life (HRQOL) has been
introduced in medical practices and assessed in many diseases
including tuberculosis (TB). The prevention of morbidity and the
maintenance of quality of life (QOL) experienced by individuals
treated for TB have become the goals of management [1].
Various generic instruments exist to assess HRQOL in patients
with TB, but a psychometrically sound disease-speciﬁc instru-
ment is sorely lacking. The present study aimed to develop and
psychometrically validate an HRQOL instrument that is multi-
dimensional in scope, including physical well-being (PWB),
functional well-being (FWB), social well-being (SWB), andemotional well-being (EWB) as well as symptoms and disease-
speciﬁc concerns.
Several disease-speciﬁc HRQOL instruments were derived
from the Functional Assessment of Chronic Illness Therapy
(FACIT) Measurement System. The FACIT Measurement System
provides an array of generic and targeted measures with multiple
beneﬁts in terms of validity, ease of administration, global
application, and interpretation. Although the Functional Assess-
ment of Chronic Illness Therapy-General (FACT-G) was developed
for use in patients with cancer, its extensions have been used and
validated in other chronic illnesses including HIV/AIDS, multiple
sclerosis, Parkinson’s disease, and rheumatoid arthritis, as well
as in the general population [2,3].ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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The study comprised two parts: 1) development of the Functional
Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB)
instrument and 2) psychometric validation of the scale.
Development of the FACIT-TB Instrument
A modular approach was followed for the development of the
FACIT-TB questionnaire in which a set of items assessing QOL
issues not sufﬁciently covered by the core FACT-G items, but
considered to be relevant to the target population, was added.
This set of items refers to disease symptoms related to the site of
infection (pulmonary region), adverse effects, other issues related
to treatment, and additional QOL dimensions such as fatigue,
fear of disease transmission, and economic burden of the illness.
The development process of an additional concerns subscale of
the new FACIT-TB instrument involved several stages: 1) concept
clariﬁcation, 2) item pool generation, 3) item reduction, and 4)
reﬁnement. Table 1 presents a summary of the stages in the
development of the additional concerns subscale of the FACIT-TB
questionnaire.
All questions asked about the last week before the admin-
istration of the questionnaire. The supplementary questions
were grouped in a separate section titled “Additional-Concerns
Items.” Feedback on any problem with wording, comprehension,
instruction, relevance of items, and the overall impression of the
measure was provided by all investigators and the measure was
further reﬁned accordingly. The response choices of the addi-
tional subscale were similar to those of the core questionnaire,
ranging from “not at all” to “very much.” Moreover, the ﬁnal
format was sent to the FACIT (the developers of FACT-G and
related instruments) for review and was further reﬁned.
Subsequently, the FACIT-TB instrument was translated and
linguistically validated in Arabic. The linguistic validation process
is composed of general procedures derived from internationally
accepted guidelines for linguistic validation and cultural adapta-
tion of the FACIT Measurement System [4]. The translatedTable 1 – Stages in the development of the FACIT-TB que
Stage Objective
1. Concept
clariﬁcation
To establish an approach for
HRQOL assessment in patients
with PTB
It in
op
fr
ex
M
2. Item pool
generation
To supply sufﬁcient and
informative items that are of
greatest interest to patients with
PTB in Iraq
The
th
ad
PT
fr
le
pa
3. Item reduction To consider the most elevant
questions
Item
re
di
po
4. Reﬁnement To reﬁne the structure of the scale The
st
in
th
FACIT, Functional Assessment of Chronic Illness Therapy; FACIT-TB, Fun
health-related quality of life; PTB, pulmonary tuberculosis; QOL, qualityquestionnaire was pretested among seven patients with pulmo-
nary TB (PTB) at the Thoracic and Respiratory Diseases Specialist
Center in Baghdad, Iraq. Patients were then interviewed to ascer-
tain whether they had any difﬁculty comprehending any questions
and to label any questions not relevant to their QOL. Furthermore,
they were requested to identify QOL issues not currently covered
by the questionnaire. A permission to develop FACIT-TB in collab-
oration with the FACIT and all related subscales and to translate
the measurement into Arabic for the study under the guidance of
the FACIT system was granted. Moreover, the study protocol,
informed consent, and other relevant documents were reviewed
and approved by the Research and Teaching Aids Division, Train-
ing and Development Center, Ministry of Health, Iraq.
The FACIT-TB questionnaire is suitable for self-administration
or face-to-face interview by a trained interviewer. For self-admin-
istration, patients are instructed to read the brief direction on the
top of the page. Patients’ correct understanding was ensured, and
they were encouraged to complete every question in chronological
order without skipping any items. During interview administra-
tion, patients were given a copy of the questionnaire as a reference
for the response options. Administration via interview was
deemed appropriate by giving adequate training to the interviewer
so as to elicit nonbiased patient responses. The health concepts
described by the scale range in score from 0 to 188 (for the 47-item
FACIT-TB), with higher scores indicating higher levels of function
and/or better health. The subjects’ responses are presented as a
proﬁle of scores calculated for each subscale. Total score can be
calculated by the sum of subscales scores.Psychometric Validation of the FACIT-TB Instrument
This phase of the study was conducted between September 1,
2012, and July 31, 2013, among consecutive patients with PTB
treated at the Thoracic and Respiratory Disease Specialist Center,
the largest center for the diagnosis, treatment, and recording of all
new and previously treated TB cases in Baghdad, Iraq. Patients
with PTB aged 18 years or older who completed at least 2 weeks of
TB treatment were included in the study. Moreover, patients withstionnaire.
Method Result
volved extensive literature review,
inion of investigators, and input
om patients, consultants, and
perts (deﬁned as credentialed
D)
The key aspects of domains
contribute to QOL in
patients with PTB
FACIT Measurement System was
e main source of items for the
ditional concerns subscale for
B infection. In addition, input
om four expert physicians with at
ast 4 years’ experience in treating
tients with TB in Iraq
Fifty candidate question for
the additional concerns
subscale of PTB infection
pools were then carefully
viewed and were examined to
scern their relevance for the
pulation with PTB in Iraq
Twenty additional concern
items
format of the instrument was
andardized with respect to
structions, header, and order of
e questions
A 47-item instrument to
assess the HRQOL for
patients with PTB in Iraq
ctional Assessment of Chronic Illness Therapy-Tuberculosis; HRQOL,
of life.
Table 2 – Proposed domains that were assumed to
contribute to the QOL in patients with PTB in Iraq.
Domain I: Physical Well-Being
 Somatic sensation of physical symptoms
 Adverse side effects of anti-TB drugs
 Energy and fatigue
Domain II: Psychological Well-Being
 Psychological reaction of TB diagnosis
 Distress about spreading the disease to others
 Social stigma
Domain III: Function Well-Being
 Effect on the activity of daily living
 Effect on work capacity
Domain IV: Social Well-Being
 Impact on the personal relationship
 Impact of social support
 Impact on sexual relationship
Domain VI: Spiritual Well-Being
 Impact on religion and relationship with God
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obstructive pulmonary disease, asthma, and other chronic dis-
eases likely to affect HRQOL, namely, diabetes mellitus and
cardiovascular disease, and hospitalized patients were excluded
from the validation study. Patients with underlying immune
suppression such as renal failure and cancer, subjects receiving
immunosuppressive drug treatment, individuals unable to read
the questionnaire who were also suffering from hearing impair-
ment, and mentally handicapped patients were also excluded.
Statistical Analyses
Psychometric and other analyses were conducted using Statistical
Package for Social Science 18 for Windows. The responses of the
total sample (n ¼ 305) were subjected to factor analysis to examine
the underlying structure of the 47 items of the FACIT-TB scale using
principal-component analysis (PCA) with orthogonal rotations. To
obtain the largest possible sample for the factor analysis, subjects
with missing data, totaling 22.62% of the entire sample (n ¼ 69), had
missing items imputed using the mean item value for the sample.
The remainders of the analyses, however, were run using only
subjects’ raw or nonimputed data. The adequacy of ﬁt of each item
in the scale was evaluated using the following criteria: Impact on personal belief
1.Domain V: EnvironmentIs the factor loading of the item greater than a cutoff point
of 0.4? Economic burden of TB disease2.
 Clinic environment
 Physical environment including pollution and climate
Domain VII: Perception
 General health perception and overall QOL
 Perspective changes
PTB, pulmonary tuberculosis; QOL, quality of life; TB, tuberculosis.How good is the conceptual ﬁt of the item with QOL domains
identiﬁed in factor analysis?
Internal consistency reliability analysis was performed by
calculating Cronbach alpha coefﬁcient. Moreover, the FACIT-TB
questionnaire was administered at two occasions for each
patient separated by an interval of 1 week to examine test-
retest reliability.Results
During the development process of the FACIT-TB instrument,
several broad domains that were assumed to contribute to the
QOL of patients with PTB in Iraq were proposed. Table 2 repre-
sents the domains of QOL affected by TB disease. Each domain
was further divided into a series of speciﬁc areas summarizing
each particular domain. In addition, nine scales represent the
patrimony of the additional concerns subscale for PTB disease.
Table 3 displays the additional concerns items and items’ code
and origin. As a result, 47 items were included in the ﬁnal
structure of the FACIT-TB questionnaire before conducting the
PCA. Moreover, information derived from the pretesting did not
require additional domains of QOL. Respondents found that the
questionnaire covered a broad spectrum of QOL in patients with
TB disease and better characterized their HRQOL.
The 305 subjects who were subjected to the validation study
ranged in age from 18 to 91 years, with a mean age of 41.59 years;
64.6% of them were men, and 28.2% were illiterate. The average
completion time of the questionnaire was 16.3  3.1 minutes.
Moreover, our results found no signiﬁcant effects for the mode of
administration of the FACIT-TB questionnaire (self-administra-
tion vs. face-to-face interview) on the reporting of HRQOL data.
Before performing the PCA, the suitability of the data for factor
analysis was assessed. Inspection of the correlation matrix revealed
the presence of many coefﬁcients of 0.3 or more. The Kaiser-Meyer-
Olkin value was 0.791, exceeding the recommended value of 0.6,
and Bartlett’s Test of Sphericity was statistically signiﬁcant (P o
0.001), supporting the factorability of the correlation matrix.
PCA revealed the presence of 12 components with eigenvalues
exceeding 1, explaining 72.6% of the total cumulative variance.
An inspection of the scree plot revealed that a clear cutoff fellafter the ﬁfth factor (Fig. 1). Therefore, ﬁve factors were retained
for further investigation according to Catell’s scree test recom-
mendation. In fact, a ﬁve-factor solution produced a readily
interpretable structure and collectively explained 53% of the total
variance. The structure was quite similar to that of the FACT-G
and the names of the factors were chosen to be as consistent as
possible with those of the core instrument, while still allowing for
modiﬁcations based on the TB-speciﬁc content of the subscales.
Because there were two items with very low factor loading,
including GS7 cross-loaded on the ﬁrst and second factors (0.23
and 0.16; respectively) and TB1 with factor loading of 0.22 on the
ﬁrst factor and 0.18 on the third factor, they were not considered
in the further reliability and validity analysis. The PCA was
performed again after the omission of these items.
The ﬁrst factor explained 25.56% of the variance and con-
tained 17 items, of which 7 were the original FACT-G PWB items
and 10 came from the expanded TB-speciﬁc concerns subscale.
As a result, this ﬁrst factor was named PWB. Table 4 contains the
result of factor analysis. The second factor (11.98% of the total
variance) contained seven items, of which six were the original
FACT-G SWB items and one was from the TB-speciﬁc concerns
subscale. This second factor was named social and economic
well-being, reﬂecting the item content related to subjects’ social
life as well as the economic burden of the disease.
Moreover, 11 items were contained in the third factor, which
accounted for 7.01% of the variance. Six of the original FACT-G
EWB items loaded highly on this factor, as did ﬁve additional
concerns subscale items. The later items mainly reﬂected con-
cerns about the social stigma of TB, such as HI10, HI2, and HI4.
Therefore, this factor was named emotional well-being/stigma of
having TB (EWB/TB). The fourth factor accounted for 6.05% of the
Table 3 – Additional concerns items and their origin.
Code Items Origin
HI7 I feel fatigued Functional Assessment of
HIV Infection (FAHI)
scale for HIV co-infected
patients
HI12 I feel weak all over FAHI scale for HIV co-
infected patients
BMT
6
I get tired easily Functional Assessment of
Cancer Therapy-Bone
Marrow Transplantation
(FACT-BMT) scale for
patients undergoing
bone marrow
transplantation
L2 I have been coughing Functional Assessment of
Cancer Therapy-Lung
(FACT-L) scale for
patients with lung
cancer
B1 I have been short of
breath
Functional Assessment of
Cancer Therapy-Breast
(FACT-B) for patients
with breast cancer
TB1 I am worried about
coughing up blood
Nil
BRM3 I am bothered by fever
(episode of high body
temperature)
Functional Assessment of
Cancer Therapy-Biologic
Response Modiﬁer
(FACT-BRM) scale for
patients receiving
biologic response
modiﬁers
B8 I am bothered by
change in weight
FACT-B for patients with
breast cancer
HI2 It is hard to tell other
people about my
infection
FAHI scale for HIV co-
infected patients
HI4 I worry about spreading
my infection
FAHI scale for HIV co-
infected patients
HI5 I am concerned about
what the future holds
for me
FAHI scale for HIV co-
infected patients
HI10 I am embarrassed by
my illness
FAHI scale for HIV co-
infected patients
TB2 My physical condition
and/or medical
treatment cause me
ﬁnancial difﬁculties
European Organization for
Research and Treatment
of Cancer (EORTC) scale
for patients with cancer
Ga1 I have a loss of appetite Functional Assessment of
Cancer Therapy-Gastric
(FACT-Ga) scale for
patients with gastric
cancer
Hep4 I have had itching Functional Assessment of
Cancer Therapy-
Hepatobiliary (FACT-
Hep) scale for patients
with hepatobiliary
cancer
Hep8 I have discomfort or
pain in my stomach
area
FACT-Hep scale for
patients with
hepatobiliary cancer
continued on next page
Table 3 – continued
Code Items Origin
TB3 Dust worsens my
symptoms
Nil
Sp10 I ﬁnd strength in my
faith or spiritual
belief
Functional Assessment of
Chronic Illness Therapy-
Spiritual Well-Being
(FACIT-Sp) scale to
assess spiritual well-
being in chronic illness
Sp11 My illness has
strengthened my
faith or spiritual
belief
FACIT-Sp scale to assess
spiritual well-being in
chronic illness
Sp3 My life has been
productive
FACIT-Sp scale to assess
spiritual well-being in
chronic illness
F
F
T
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FWB items; accordingly, this factor was named FWB. Three items
loaded most highly on the ﬁfth factor, which accounted for 4.36%
of the variance. These items reﬂected spirituality. This factor was
conﬁdently named spiritual well-being.
The internal consistency estimate for the FACIT-TB total score
was 0.92. The Cronbach alpha coefﬁcients for the FACIT-TB
subscales were uniformly high across all the subscales, ranging
from 0.81 to 0.93. Table 5 contains the mean  SD and Cronbach
alpha coefﬁcients for the FACIT-TB total score and for each
subscale score. Test-retest reliability analysis was performed by
calculating items’ intraclass correlation coefﬁcients within a
recall period of 1 week. Out of 305 subjects, 267 patients with
PTB agreed to participate in test-retest reliability study. Intraclass
correlation coefﬁcients ranged from 0.72 to 0.92.Discussion
There is considerable evidence that the somatic sensation of
physical symptoms and the adverse effects of TB therapy neg-
atively affect the QOL of patients with TB [5,6]. In addition, a
study carried out in China using the Medical Outcomes Study
short-form 36 health survey (SF-36) questionnaire demonstratedig. 1 – The scree plot for 47-item FACIT-TB. FACIT-TB,
unctional Assessment of Chronic Illness Therapy-
uberculosis.
Table 4 – Factor loading of 45-item FACIT-TB
subscale items.
Subscale and items Factor loading
with identiﬁed
subscale
Physical well-being
I feel ill 0.827
I get tired easily 0.794
I have a lack of energy 0.784
I have pain 0.782
I feel weak all over 0.771
I feel fatigued 0.735
I have been short of breath 0.730
I have nausea “a sense of vomiting
outbreak”
0.700
Because of my physical condition, I
have trouble meeting the needs of my
family
0.688
I am bothered by fever (episode of
high body temperature)
0.650
I am forced to spend time in bed 0.645
I have discomfort or pain in my
stomach area
0.628
I have had itching 0.626
I have a loss of appetite 0.615
I have been coughing 0.579
I am bothered by side effects of
treatment
0.520
Dusts worsen my symptoms 0.394
Social and economic well-being
I feel close to my friends 0.902
I get emotional support from my
family
0.886
I am satisﬁed with family
communication about my illness
0.844
My family has accepted my illness 0.843
I feel close to my partner (or the
person who is my main support)
0.826
I get support from my friends 0.827
My physical condition and/or medical
treatment cause me ﬁnancial difﬁculties
0.320
Emotional well-being/Stigma of having TB
I worry that my condition will get worse 0.785
I worry about dying 0.712
I am concerned about what the future
holds for me
0.654
I am embarrassed by my illness 0.583
It is hard to tell other people about my
infection
0.574
I am losing hope in the ﬁght against my
illness
0.501
I am bothered by change in weight 0.484
I worry about spreading my infection 0.481
I feel nervous 0.427
I feel sad 0.376
I am satisﬁed with how I am coping with
my illness
0.344
Functional well-being
I am content with the quality of my life
right now
0.770
My work (include work at home) is
fulﬁlling
0.693
continued on next page
Table 4 – continued
Subscale and items Factor loading
with identiﬁed
subscale
I am able to work (include work at home) 0.691
I am able to enjoy life 0.667
I am enjoying the things I usually do for
fun
0.616
I have accepted my illness 0.507
I am sleeping well 0.498
Spiritual well-being
I ﬁnd strength in my faith or spiritual
belief
0.886
My illness has strengthened my faith or
spiritual belief
0.869
My life is still productive 0.663
FACIT-TB, Functional Assessment of Chronic Illness Therapy-
Tuberculosis.
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treated for TB compared with the general population [7]. More-
over, prolonged cough, fatigue, and weight loss are most con-
cerning for patients with TB and the reason patients seek medical
care [5,6,8,9]. Thus, items with respect to these symptoms were
considered. Patients also reported other classic symptoms of PTB
as key features of the disease including fever, hemoptysis,
decrease appetite, and shortness of breath [10].
Guo et al. [11] ﬁrst reported the impact of adverse drug
reaction (ADR) induced by ﬁrst-line anti-TB drugs on patients’
HRQOL using the SF-36 questionnaire. The ﬁnding showed that
ADRs resulted in more decrement in HRQOL. In addition, patients
with lower baseline SF-36 scores had a higher risk of developing
ADRs during the ﬁrst 3 months of TB treatment [11]. ADRs due to
anti-TB medications such as epigastric distress, pruritus, itching,
hepatotoxicity, visual disturbances, and arthralgia are common
[12]. In view of this, items regarding the impact of the most
common ADRs on patients’ HRQOL were supplemented.
A large proportion of patients perceive stigma of TB including
fear of disease transmission, values and attitudes associated with
shame, blame, and the adverse social judgment about a patient
identiﬁed with TB, as well as disclosure of disease status [13–16].
Such perception might have a great impact on the SWB and the
EWB of patients with TB and their families [17]. Therefore,
questions to capture the social stigma linked with TB were
included.
A review of English language literature demonstrates the
impact of TB on patients’ spiritual and ﬁnancial well-being [18].
In many cultures, TB is considered a God-given punishment for
sins and patients may ask God for forgiveness to attain cure
[19,20]. Furthermore, it is difﬁcult to separate spirituality, reli-
gion, and culture because patients’ acceptance of their illness
may stem from cultural acceptability of the disease [18]. A
qualitative research in a culturally diverse setting reported that
TB enhanced patients’ spirituality and faith in God was a
considerable support for them while they were ill [5]. Moreover,
patients reported that being sick was considered a “wake-up
call” to adopt a productive and healthier lifestyle and that
recovering from a serious illness made one want to thank God
for a chance to get better [5,21]. Items related to personal belief,
religion, and relationship with God were added to the additional
concerns subscale.
Although TB treatment in Iraq is sponsored by the govern-
ment, the additional nonmedication costs such as consultation
Table 5 – Mean, SD, and Cronbach α coefﬁcient of FACIT-TB and of each subscale.
Scale/subscale (no. of items) Mean  SD Possible score range Observed score range Cronbach α
Physical well-being (17) 31.25  17.26 0–68 2–67 0.93
Social and economic well-being (7) 22.54  5.37 0–28 1–28 0.84
Emotional well-being/Stigma of having TB (11) 20.17  9.82 0–44 1–43 0.81
Functional well-being (7) 13.28  7.31 0–28 0–28 0.84
Spiritual well-being (3) 9.74  2.63 0–12 0–12 0.82
FACIT-TB (45) 96.99  29.80 0–180 17–165 0.92
FACIT-TB, Functional Assessment of Chronic Illness Therapy-Tuberculosis; TB, tuberculosis.
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diture incurred for travel, lodging, special food, and persons
accompanying patients, loss of wages due to illness, and
decreased earning ability due to TB affect the ﬁnancial state of
individuals and families [22–25]. Studies reported that the low
case detection and treatment completion rate of TB may partly be
due to economic consequences of the diagnosis and treatment of
the disease [25]. Thus, a question on the economic burden of TB
was considered in constructing the subscale. According to
patients’ opinion, environmental factors including pollution and
large amount of dust in the air in Iraq markedly inﬂuence their
well-being; therefore, an item to assess the impact of environ-
mental effect was supplemented.
There are a number of reasons that items were selected from
previous inventories. First, the selected items have gone through
a repeated testing process and have proven themselves to be
advantageous and psychometrically sound. Second, it saves time
and work and the need for constructing new ones [2,26]. Third,
there are only a limited number of ways to ask about a speciﬁc
problem. If the scale is trying to tap symptoms of TB disease, for
instance, it is difﬁcult to ask about cough in a way that has not
been used previously [27].
This study is to our knowledge the ﬁrst to develop and assess
psychometric properties and reliability of TB-speciﬁc instruments
for patients with PTB in Iraq. In terms of the mode of admin-
istration, our ﬁndings demonstrated technical equivalence in the
sample of patients with PTB in Iraq [28]. Flexibility is important in
selecting methods and modes of questionnaire administration to
accommodate the needs of patients with diverse social, educa-
tional, and functional skills [29]. Moreover, the result of PCA
demonstrated a ﬁve-factor structure that corresponded mostly to
the FACT-G subscales [2]. Several items, however, did not pass at
least one of the two criteria described for the evaluation of the
adequacy of ﬁt for each item. These included four items with
factor loadings of less than 0.4 on all factors.
Item GE1 loaded on both the ﬁrst and the third factors (0.443
and 0.380, respectively). This item was retained in the third factor
because it did have a reasonably good ﬁt with the items in this
factor. The decision to retain item GE1 in the third factor was
consistent with the FACT-G core questionnaire [3], and to
produce a subscale that is empirically sound and has a sense of
conceptual coherence. Similarly, item B8 was evaluated with both
PWB and EWB/TB (factor loading of 0.368 and 0.496, respectively).
From Iraqi people’s perspectives, someone bothered by change in
weight reﬂects the mental image of the body ﬁgure, in other
words, someone’s feelings about his or her body. Furthermore,
the item loaded most highly on the EWB/TB factor and there is
considerable evidence of the association between weight changes
and EWB [30,31]. Spontaneously, factor 3 was considered a more
attractive location for this item.
Because Iraqi people, particularly women, tend to regard sex
as a private and sensitive topic, a relatively low item response
rate was demonstrated for the sex-related item. All Arab
cultures, however, share the same traditional conservative viewof sexuality [32]. Furthermore, a study conducted in Mainland
China to assess the reliability and validity of the Chinese
version of the FACT-Cervix in women with cervical cancer also
revealed that the Chinese culture retains conservative values
regarding sexual topics, which was conﬁrmed by the low item
response rate for item GS7 [33]. The tendency of Iraqi people to
be less sexually outspoken does not mean that sexual problems
are not experienced or that such problems may not be detri-
mental to the HRQOL of patients with PTB in Iraq. Although the
Iraqi culture’s traditional conservative view obscures under-
standing of the true sexual concerns for patients, health care
providers are expected to clarify this issue and to ﬁnd more
proﬁcient solutions. Thus, this challenging task may improve
the patients’ acceptability of the sex-related item within the
instrument.
FACIT-TB had excellent internal consistency reliability,
whereas the reliability of the subscales ranged from good to
excellent according to the commonly accepted rule of thumb for
describing internal consistency reliability using Cronbach alpha
[34]. In comparison, the internal consistency estimate for the
original FACT-G total score and the subscales was also uniformly
high. The Cronbach alpha coefﬁcient for the FACT-G total score
was 0.872 and for all subscales ranged from 0.736 to 0.817 [3].
FACIT-TB is the ﬁrst measure speciﬁcally designed to assess the
HRQOL of patients with TB disease. The measure will beneﬁt from
ongoing enhancements. Speciﬁcally, research should further
develop the psychometric properties of the FACIT-TB. In addition,
given the cross-sectional nature of this initial validation study,
future longitudinal research should examine the responsiveness of
the measure to longitudinal clinical change. Future research using
FACIT-TB in samples with greater sociodemographic and clinical
heterogeneity will also advance the generalizability of the measure.Conclusions
A rigorous method was applied in the development of the FACIT-
TB scale to better characterize QOL in patients with TB. The 45-
item FACIT-TB is a psychometrically sound instrument that
portrays multiple important dimensions of HRQOL, and it is a
part of the FACIT Measurement System. The development of the
TB-speciﬁc HRQOL measure will provide an additional parameter
to fully evaluate the effectiveness of treatment and treatment
strategies, as well as help health care planners focus on the
nonmedication aspects of TB management and allow them to
allocate funds where these are most needed.Acknowledgments
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